Nimbus Therapeutics

Nimbus Therapeutics is a biotech company in Cambridge, United States, founded in 2009. It has raised $572.0M across 8 rounds, most recently a $210.0M Growth Equity in September 2023.

Homepage

Employees
51–200
Founded
2009
Business Model
B2B
Total Funding
$572.0M
Last Round
$210.0M Growth EquitySep 2023
Rounds
8

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 8 funding rounds and 11 investors for this company. The full record is or through the API.

About

Nimbus Therapeutics is a clinical-stage biotechnology company founded in 2009 as Nimbus Discovery, focused on developing breakthrough small molecule medicines through precision, structure-based drug design. The company has advanced four programs into clinical development and achieved major partnership outcomes, including Gilead's 2016 acquisition of its ACC inhibitor program for MASH and liver disease (up to $1.2B) and Takeda's 2022 acquisition of its TYK2 inhibitor program (up to $6B), along with collaborations with Celgene, Genentech, and Eli Lilly. Nimbus has raised over $630 million in equity financing and returned more than $4 billion to investors from partnership deals.

Summary

It lists 51–200 employees. It has raised $572.0M in total across 8 rounds, most recently a $210.0M Growth Equity round in Sep 2023. Investors include SR One, Atlas Venture and BVF Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Growth EquityGrowth EquitySep 2023
$210.0M

Sign up to see all 8 events

Funding: Grant through Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Nimbus Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/nimbus-therapeutics"><img src="https://indexed.vc/api/badge/company/nimbus-therapeutics" alt="Nimbus Therapeutics on Indexed.vc" width="260" height="76" /></a>